TG Therapeutics Inc (NASDAQ:TGTX)

Delayed Data
As of Mar 23
 -0.80 / -5.08%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for TG Therapeutics Inc have a median target of 26.50, with a high estimate of 36.00 and a low estimate of 21.50. The median estimate represents a +77.26% increase from the last price of 14.95.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in TG Therapeutics Inc. This rating has held steady since February, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
May 04

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 12.32%
Growthannually 12.04%


Growthquarterly 2.36%
Growthannually 15.99%
Key to the earnings and sales forecast charts.